The global probiotics market was estimated at US$ 63.11 billion in 2021 and is expected to hit around US$ 133.92 billion by 2030, poised to grow at a CAGR of 8.7% during the forecast period 2022 to 2030..
The market is driven by the growing consumer inclination towards preventive healthcare in conjunction with the development of efficient probiotic strains. Probiotics, when consumed in adequate amounts, have desirable effects on the body, such as improved gut health and reduced intestinal inflammation. Probiotics play a great role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Thus, rising awareness regarding preventive healthcare is expected to boost the market growth over the forecast period.
Preventive healthcare includes a healthy lifestyle and dietary choices that help prevent the occurrence of diseases. Awareness regarding preventive healthcare is on the rise due to various factors, such as increasing disposable income, improving the standard of living, and growth in the aging population. Easy availability of information pertaining to preventive healthcare on the internet is also contributing favorably to the rising awareness.
The market in the U.S. is characterized by the presence of demographic-specific probiotics, such as for geriatrics and genders. These niche markets have offered regional players the chance to adopt different strategies to enhance their product portfolio and maximize their resources. Excessive demand for probiotic-based food and beverage products and dietary supplements is expected to drive the U.S. market over the next few years.
Regulations pertaining to the use of probiotics in nutraceuticals, nutricosmetics, and dietary supplements, especially infant formulas, are extremely stringent in the U.S. and are expected to pose a challenge for the regional market players. This has resulted in stagnancy in the innovation in probiotic products for baby boomers. On the other hand, in 2016, 204 probiotic-based products for adults were launched in the country.
Report Scope of the Probiotics Market
Report Coverage |
Details |
Market Size |
USD 133.92 Billion by 2030 |
Growth Rate |
CAGR of 8.7% from 2021 to 2030 |
Base Year |
2021 |
Largest Market |
Asia Pacific |
Fastest Growing Market |
North America |
Forecast Period |
2022 to 2030 |
Segments Covered |
Application, End Use, Distribution Channel, Function, Form, Ingredient, Region |
Companies Mentioned |
Yakult Honsha Co., Ltd., BioGaia AB, Danone, E. I. du Pont de Nemours and Company, Probi AB, Ganeden, Inc., Protexin, Nestle S.A., Chr. Hansen Holding A/S, Lifeway Foods, Inc. |
Ingredient Insights
Based on ingredient, the bacteria segment garnered the highest probiotics market share in 2020 due to surge in demand for bacteria derived probiotics food products. This is attributed to the growth in health issues that have encouraged market players to invest in R&D and launch new & innovative probiotics products.
Application Insights
Based on application, the food & beverages segment accounted largest revenue share of over 75% in 2021 due to the rising popularity of probiotic functional foods & potables among consumers. Growth in consumer awareness, faith in its efficacy, and safety are some of the factors driving the market of probiotics. The food & beverages segment is the largest market segment across the regions. Consumers are now taking a visionary approach towards preventing chronic conditions. China and Japan are the two dominant markets in the Asia Pacific, and the Japanese market is projected to reach its maturity level during the forecast period.
On the other hand, the animal feed segment is projected to record the fastest growth during the cast. The ban on synthetic antimicrobial growth promoters (AGP’s) in Europe is a factor driving the market. The motive behind the ban was to check the practice of using antibiotics, antimicrobials, and other medicines for promoting the growth of livestock in order to rise the production of meat, milk, and other products.
Regional Insights
Asia Pacific led the global market with a revenue share of over 71% in 2021. The region is witnessing a substantial rise in consumer awareness due to competitive strategies adopted by the global players. Strong demand from countries, such as India, China, and Australia, is contributing to the overall growth. The rising population, coupled with the rising disposable income and improving the standard of living, is also expected to cater to the regional market growth.
In the recent past, due to a lack of technology, the market was flooded with probiotics that lacked stability at room temperature. This issue of quality was addressed as major companies introduced technologies, such as microencapsulation, which enhance the stability and life of the probiotic bacteria. In addition, ongoing R&D activities for the development of efficient strains that have a broad spectrum of treatment and can withstand high temperatures are expected to benefit the regional market growth over the forecast period.
North America is expected to witness considerable growth over the forecast period. Continued investments from manufacturers in the food and beverage and pharmaceutical industries are anticipated to contribute to the regional market growth. The regional players are investing in R&D to come up with new products to cater to consumers of different age groups and genders. Such factors are expected to accelerate the growth of the market over the forecast period.
Some of the prominent players in the Probiotics Market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
By Application
By End Use
By Distribution Channel
By Ingredient
By Function
By Form
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Probiotics Market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Form Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Probiotics Market
5.1. COVID-19 Landscape: Probiotics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Probiotics Market, By Application Type
8.1. Probiotics Market, by Application Type, 2022-2030
8.1.1. Food & Beverages
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Dietary Supplements
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Animal Feed
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Probiotics Market, By End Use Type
9.1. Probiotics Market, by End Use Type, 2022-2030
9.1.1. Human
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Animal
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Probiotics Market, By Ingredient Type
10.1. Probiotics Market, by Ingredient Type, 2022-2030
10.1.1. Bacteria
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Synthetic
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Probiotics Market, By Function Type
11.1. Probiotics Market, by Function Type, 2022-2030
11.1.1. Regular
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Preventative Healthcare
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Therapeutic
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Probiotics Market, By Distribution Channel
12.1. Probiotics Market, by Distribution Channel, 2022-2030
12.1.1. Hypermarkets/Supermarkets
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Pharmacies/Drugstores
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Online Stores
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Specialty Stores
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Probiotics Market, By Form
13.1. Probiotics Market, by End Use Type, 2022-2030
13.1.1. Dry
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Liquid
13.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Probiotics Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Application (2017-2030)
14.1.2. Market Revenue and Forecast, by End Use (2017-2030)
14.1.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.1.4. Market Revenue and Forecast, by Function (2017-2030)
14.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.6. Market Revenue and Forecast, by Form (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Application (2017-2030)
14.1.7.2. Market Revenue and Forecast, by End Use (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Function (2017-2030)
14.1.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.8.1. Market Revenue and Forecast, by Form (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Application (2017-2030)
14.1.9.2. Market Revenue and Forecast, by End Use (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Function (2017-2030)
14.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.11. Market Revenue and Forecast, by Form (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.4. Market Revenue and Forecast, by Function (2017-2030)
14.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.6. Market Revenue and Forecast, by Form (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.8.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.9. Market Revenue and Forecast, by Function (2017-2030)
14.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.10.1. Market Revenue and Forecast, by Form (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.11.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.12. Market Revenue and Forecast, by Function (2017-2030)
14.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.14. Market Revenue and Forecast, by Form (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.15.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Function (2017-2030)
14.2.16. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.16.1. Market Revenue and Forecast, by Form (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.17.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Function (2017-2030)
14.2.18. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.18.1. Market Revenue and Forecast, by Form (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.6. Market Revenue and Forecast, by Form (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.7.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.9. Market Revenue and Forecast, by Form (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.10.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.11.1. Market Revenue and Forecast, by Form (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.12.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.12.6. Market Revenue and Forecast, by Form (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.13.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.13.6. Market Revenue and Forecast, by Form (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.6. Market Revenue and Forecast, by Form (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.7.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.9. Market Revenue and Forecast, by Form (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.10.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.12. Market Revenue and Forecast, by Form (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.13.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.13.6. Market Revenue and Forecast, by Form (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.14.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.14.6. Market Revenue and Forecast, by Form (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Application (2017-2030)
14.5.2. Market Revenue and Forecast, by End Use (2017-2030)
14.5.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.5.4. Market Revenue and Forecast, by Function (2017-2030)
14.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.6. Market Revenue and Forecast, by Form (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Application (2017-2030)
14.5.7.2. Market Revenue and Forecast, by End Use (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Function (2017-2030)
14.5.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.8.1. Market Revenue and Forecast, by Form (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Application (2017-2030)
14.5.9.2. Market Revenue and Forecast, by End Use (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Function (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Form (2017-2030)
Chapter 15. Company Profiles
15.1. Yakult Honsha Co., Ltd.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. BioGaia AB
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Danone
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. E. I. du Pont de Nemours and Company
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Probi AB
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Ganeden, Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Protexin
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Nestle S.A.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Chr. Hansen Holding A/S
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Lifeway Foods, Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms